Mirum Pharmaceuticals received positive analyst rating updates, including buy ratings and raised price targets, from multiple firms including CLSA and Morgan Stanley.
1 report, 1 independent
Updated Jun 16
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Mirum Pharmaceuticals received positive analyst rating updates, including buy ratings and raised price targets, from multiple firms including CLSA and Morgan Stanley.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Mirum Pharmaceuticals
biopharmaceutical company
-
Morgan Stanley
U.S. investment bank